STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE

摘要

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.

主权项

1. A stable fixed dose aqueous pharmaceutical composition for nasal administration to a human, said composition comprising about 0.001% w/w to about 0.075% w/w mometasone or its salt and about 0.5 w/w to about 0.8% w/w olopatadine or its salt.